Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016:A Systematic…

By Paula Esther Moraga-Serrano. 2018

839 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/783411b3ff0a9bb8823cc8cf46fe1a910d987ea3

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Armstrong
2. N. Shore
3. A. Azad
4. A. Alcaraz
5. B. Baron
6. Lucy F. Chen
7. A. Stenzl
8. A. Villers

Citations in the corpus

• ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer (2019, background): “4 million patients in 2016; mortality was 381,000.(1) In the United States, 174,650 new cases of prostate cancer are expected in 2019, with 31,620 anticipated deaths.”